Market Movers (8-K)
See all →OID
Pyxus International, Inc. announced the outcomes of its 2026 annual shareholder meeting, including the election of directors and ratification of auditors.
OID
Pyxus International announced its first quarter fiscal 2027 results, showing a decrease in sales but improved gross profit margin and a strengthened balance sheet, while maintaining full-year guidance.
OID
Pyxus International announced robust fourth quarter and fiscal year 2026 financial results, highlighted by a 35.2% year-over-year increase in Q4 net sales and record full-year Adjusted EBITDA.
OID
Pyxus International, Inc. announced strong third-quarter fiscal 2026 results, including $16.9 million in net income and adjusted EBITDA equal to last year's record, while reaffirming full-year guidance.
OID
Pyxus International, Inc. announced solid second quarter fiscal 2026 results, achieving gross margin expansion and increased operating income, leading to updated full-year sales and adjusted EBITDA guidance.
Better than expected
OID
Pyxus International, Inc. shareholders re-elected all director nominees and approved the independent auditors, executive compensation, and the 2020 Incentive Plan at their 2025 annual meeting.
Quarterly Earnings (10-Q)
See all →OID
Pyxus International reported a net loss and a 14% decrease in revenue for the first quarter ended June 30, 2026, impacted by lower sales prices and shipment timing, though liquidity remains a focus.
Worse than expected
OID
Pyxus International reports a significant drop in third-quarter and year-to-date net income and sales, driven by lower leaf product volumes and increased operational costs, despite improved gross margin percentage.
Worse than expected
Capital raise
Delay expected
OID
Pyxus International reported a slight increase in Q2 sales and a reduced net loss, driven by higher processing volumes and improved gross margins, despite a year-to-date sales decline.
Capital raise
Worse than expected
OID
Pyxus International, Inc. reported a net loss of $15.8 million for the quarter ended June 30, 2025, a significant decline from the prior year's profit, driven by lower sales volumes.
Capital raise
Worse than expected
OID
Pyxus International's Q3 2024 results show significant revenue growth driven by increased sales prices and kilo volumes, alongside strategic debt reduction efforts.
Better than expected
OID
10-Q: Pyxus International Reports Mixed Results Amidst Supply Chain Challenges and Debt Reduction Efforts
Pyxus International's Q2 2024 results show a revenue increase driven by higher prices, but profitability was impacted by supply chain issues and regional mix, while the company continued to reduce its long-term debt.
Worse than expected
Delay expected
Annual Reports (10-K)
OID
Pyxus International, Inc. announced its fiscal year 2026 results, showing a slight decrease in revenue but an increase in gross profit and operating income, driven by larger crops and processing efficiencies.
OID
Pyxus International, a global agricultural company, announced a substantial increase in sales and net income for fiscal year 2025, alongside a notable reduction in its overall debt, despite persistent market undersupply and inflationary pressures.
Better than expected
OID
Pyxus International's fiscal year 2024 saw a 6.1% increase in revenue driven by higher pricing, despite a slight decrease in volume, and strategic debt reduction.
Better than expected
Insider Trading (Form 4)
See all →OID
Pyxus International director Richard Topping received an award of 10,980 restricted stock units, contingent on continued service and specific vesting conditions.
OID
Pyxus International director Cynthia P. Moehring received an award of 10,980 restricted stock units, vesting based on service and specific corporate events.
OID
Pyxus International Director Robert David George was awarded 10,980 restricted stock units, vesting contingent on continued service and specific corporate events.
OID
Pyxus International, Inc. director Patrick J. Bartels Jr. was granted 10,980 restricted stock units, contingent on service and specific vesting conditions.
OID
Pyxus International Director John Alphin received an award of 10,980 restricted stock units, contingent on service and specific vesting conditions.
OID
Barclays PLC and related entities are no longer subject to Section 16 reporting requirements due to the unwind of certain stock borrow and repurchase transactions related to Pyxus International, Inc.
Proxy Statements (Def-14A)
OID
Pyxus International, Inc. has announced its 2026 Annual Meeting of Shareholders, scheduled for August 13, 2026, to elect directors, ratify auditors, and vote on executive compensation.
OID
Pyxus International, Inc. announced the appointment of Dustin L. Styons as Executive Vice President and Chief Financial Officer, formalizing his interim role effective July 23, 2025.
OID
Pyxus International, Inc. will hold its 2025 Annual Meeting virtually on August 14, 2025, to elect directors, ratify auditors, approve executive compensation, and expand its incentive plan, following a fiscal year marked by significant net income improvement and strategic debt repurchases.
Better than expected
OID
Pyxus International will hold its annual shareholder meeting virtually on August 15, 2024, to vote on director elections, auditor ratification, executive compensation, and an amended incentive plan.